权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

The New Family of NEET Proteins: 2Fe-2S Protein Mediated Health and Disease

NEET 蛋白新家族：2Fe-2S 蛋白介导的健康和疾病

基本信息

批准号：
8916786
负责人：
PATRICIA A JENNINGS
金额：
$ 28.53万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN DIEGO
依托单位国家：
美国
项目类别：
财政年份：
2012
资助国家：
美国
起止时间：
2012-09-21 至 2016-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8916786
关键词：
Aging Alzheimer&apos s Disease Amyotrophic Lateral Sclerosis Apoptosis Apoptotic Area Autophagocytosis BCL-2 Protein BCL2 gene Binding Binding Sites Biochemical Biochemical Process Biological Blood Glucose Cell Death Process Cell Survival Central obesity Cognitive deficits Complex Coronary artery Diabetes Mellitus Disease Drug Design Electron Transport Endoplasmic Reticulum Epidemic Family Future Goals Health Homologous Gene Human Hypertension In Vitro Inflammation Investigation Iron Lead Limb structure Longevity Malignant Neoplasms Mediating Metabolic syndrome Mitochondria Mitochondrial Proteins Molecular Multiple Sclerosis Mutation Natural Product Drug Neurodegenerative Disorders Non-Insulin-Dependent Diabetes Mellitus Nuclear Obesity Obesity associated disease Optic Atrophy Outer Mitochondrial Membrane Oxidation-Reduction Oxidative Phosphorylation Oxidative Stress Oxygen Pathology Peroxisome Proliferator-Activated Receptors Pharmaceutical Preparations Pioglitazone Play Premature aging syndrome Property Protein Binding Protein Family Protein S Proteins Regulation Reporting Resveratrol Role Structure Therapeutic Intervention Thiazolidinediones Thinking Wolfram Syndrome World Health computer studies deafness drug candidate drug development early onset insulin sensitizing drugs interest new therapeutic target novel novel therapeutics oxidation protein protein interaction small molecule targeted treatment transcription factor

项目摘要

DESCRIPTION (provided by applicant): The rise in obesity worldwide parallels a dramatic increase in obesity-associated diseases, most notably type-II diabetes. This disease is predicted to reach epidemic proportions in the next several decades. Thus, understanding the biochemical processes underlying type-II diabetes and identifying new targets for therapeutic intervention are critical for national and world health. Some of the most widely prescribed insulin-sensitizing drugs to treat type-II diabetes belong to the thiazolidinedione (TZD) class of molecules. These drugs were found to also reduce many of the pathologies related to metabolic syndrome including hypertension, abdominal obesity, coronary artery inflammation, multiple sclerosis, Alzheimer's disease and Amyotrophic lateral sclerosis. While the TZDs were originally thought to exert their effects solely through activation of the nuclear transcription factor PPAR¿, it is nw known that many of the beneficial effects are mediated in a PPAR¿-independent manner. The TZDs were recently shown to interact with a novel mitochondrial protein target called mitoNEET. We reported that the protein mitoNEET is a redox-active, pH-labile 2Fe-2S cluster containing protein in the outer mitochondrial membrane. This is the only known Fe-S protein in the outer mitochondrial membrane. In addition, we discovered that MitoNEET plays an important role in iron management under oxidative stress conditions. Miner1, an endoplasmic reticulum homolog of mitoNEET, is important in maintaining health and longevity and interacts with proteins associated with cancer as well as neurodegenerative diseases. These proteins have emerged as important new therapeutic targets in diseases ranging from diabetes to Alzheimer's. The focus of this proposal is the structural, biochemical and functional characterization of this novel protein family. Specifically, we are investigating the molecular determinants of drug binding as a function of changes in oxidation state and asking how drug binding impacts newly discovered protein-protein interactions that are involved in regulating cell survival and death processes. The proposed studies are of both fundamental significance in understanding this protein-drug recognition as well as the identification of novel therapeutics.

描述（由申请人提供）：全球肥胖症的增加与肥胖相关疾病的急剧增加相平行，最明显的是II型糖尿病。据预测，这种疾病在今后几十年内将达到流行病的程度。因此，了解II型糖尿病的生化过程并确定治疗干预的新目标对国家和世界健康至关重要。治疗II型糖尿病的一些最广泛处方的胰岛素增敏药物属于噻唑烷二酮（TZD）类分子。发现这些药物还减少许多与代谢综合征相关的病理，包括高血压、腹部肥胖、冠状动脉炎症、多发性硬化、阿尔茨海默病和肌萎缩侧索硬化。虽然TZDs最初被认为仅通过激活核转录因子PPAR发挥其作用，但目前已知许多有益作用是以不依赖PPAR的方式介导的。TZDs最近被证明与一种名为mitoNEET的新型线粒体蛋白质靶点相互作用。我们报道了蛋白mitoNEET是一个氧化还原活性，pH不稳定的2Fe-2S簇包含在线粒体外膜蛋白。这是线粒体外膜中唯一已知的Fe-S蛋白。此外，我们发现MitoNEET在氧化应激条件下的铁管理中起着重要作用。Miner 1是mitoNEET的内质网同源物，在维持健康和长寿方面很重要，并与癌症和神经退行性疾病相关的蛋白质相互作用。这些蛋白质已经成为从糖尿病到阿尔茨海默氏症等疾病的重要新治疗靶点。该提案的重点是该小说的结构、生化和功能表征蛋白质家族具体来说，我们正在研究药物结合的分子决定因素作为氧化态变化的函数，并询问药物结合如何影响新发现的蛋白质-蛋白质相互作用，这些相互作用参与调节细胞存活和死亡过程。的所提出的研究对于理解这种蛋白质-药物识别以及鉴定新的治疗剂都具有根本的意义。

项目成果

期刊论文数量（12）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

Geometrical Frustration in Interleukin-33 Decouples the Dynamics of the Functional Element from the Folding Transition State Ensemble.

Interleukin-33 中的几何挫败将功能元件的动力学与折叠过渡态整体解耦。

DOI：
10.1371/journal.pone.0144067
发表时间：
2015
期刊：
PloS one
影响因子：
3.7
作者：
Fisher,KaitlinM;Haglund,Ellinor;Noel,JeffreyK;Hailey,KendraL;Onuchic,JoséN;Jennings,PatriciaA
通讯作者：
Jennings,PatriciaA

Learning from cancer how to defeat bacteria.

从癌症中学习如何击败细菌。

DOI：
10.1073/pnas.1222882110
发表时间：
2013
期刊：
Proceedings of the National Academy of Sciences of the United States of America
影响因子：
11.1
作者：
Onuchic,JoséN;Jennings,PatriciaA;Ben-Jacob,Eshel
通讯作者：
Ben-Jacob,Eshel

The unique fold and lability of the [2Fe-2S] clusters of NEET proteins mediate their key functions in health and disease.

DOI：
10.1007/s00775-018-1538-8
发表时间：
2018-06
期刊：
Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry
影响因子：
0
作者：
Karmi O;Marjault HB;Pesce L;Carloni P;Onuchic JN;Jennings PA;Mittler R;Nechushtai R
通讯作者：
Nechushtai R

DOI：
10.1371/journal.pone.0139699
发表时间：
2015
期刊：
PloS one
影响因子：
3.7
作者：
Lipper CH;Paddock ML;Onuchic JN;Mittler R;Nechushtai R;Jennings PA
通讯作者：
Jennings PA

Activation of apoptosis in NAF-1-deficient human epithelial breast cancer cells.

DOI：
10.1242/jcs.178293
发表时间：
2016-01-01
期刊：
Journal of cell science
影响因子：
4
作者：
Holt SH;Darash-Yahana M;Sohn YS;Song L;Karmi O;Tamir S;Michaeli D;Luo Y;Paddock ML;Jennings PA;Onuchic JN;Azad RK;Pikarsky E;Cabantchik IZ;Nechushtai R;Mittler R
通讯作者：
Mittler R